Blue Jet Healthcare Share Price Falls 19% in 2 Days After Weak Q3 FY26 Earnings

Blue Jet Healthcare share price (NSE: BLUEJET) fell sharply, hitting a 52-week low near ₹358 on the BSE. The stock has declined about 19% in just 2 trading sessions following disappointing December-quarter earnings and is now trading close to its IPO issue price of ₹346. This fall came even as the broader BSE Sensex showed only minor movement.

Blue Jet Healthcare Q3FY26 Financial Performance

During Q3FY26, the company reported a significant slowdown:

• Revenue dropped nearly 40% year-on-year due to lower sales of pharma intermediates and artificial sweeteners
• EBITDA fell by over 60%, and net profit dropped by around 59% year-on-year

Lower demand, inventory adjustments at customer sites, and pricing pressure were key reasons for the weak performance.

Read More: RBI to Overhaul Lead Bank Scheme for Enhanced Effectiveness!

Business Strengths and Expansion Plans

Despite near-term pressure, Blue Jet Healthcare has a strong global presence, exporting to more than 50 countries and earning most of its revenue from international markets. The company is a leading Indian maker of contrast media intermediates used in MRI, CT, and X-ray diagnostics and also supplies intermediates for bempedoic acid along with high-intensity sweeteners.

Conclusion

Blue Jet Healthcare’s sharp stock decline reflects weak quarterly earnings, margin pressure. While long-term growth drivers and expansion plans remain in place, near-term recovery will depend on demand improvement, margin stability, and successful execution of new projects.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.